MedTrace Logo

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

NCT03959423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

This study is a Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

AHCL insulin pump system

670G 4.0 system with GS3; 780G system with G4S (continued access phase);

Sponsors & Collaborators

  • Medtronic Diabetes

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-24
Primary Completion
2021-03-17
Completion
2023-10-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03959423 on ClinicalTrials.gov